CONCORDBIO Bleeds for 13th Day – Down 25% Since July Peak

On 11 August 2025,

shares extended losses, falling 7% in early trade, marking the thirteenth straight negative session. Since its 24 July 2025 peak, the stock has declined nearly 25%, highlighting sustained selling pressure. Market sentiment remains weak, with traders cautious amid the persistent downtrend. From a technical perspective, ₹1,478 is the immediate support to watch; a breach could open the path toward the major support at ₹1,330. Holding above these levels may offer a short-term rebound opportunity, but a decisive break below ₹1,330 could accelerate the downside. Price action around these supports will be critical in determining the stock’s near-term trend. Net sales, profit before tax, and profit after tax declined sharply, with operating profit and margin at five-quarter lows. Disclaimer: This document is prepared by SEBI RRA (Reg. No. INH000016649), solely for informational purposes. It does not constitute investment advice, trading recommendations, or an offer to buy/sell any securities. Information is based on sources deemed reliable but is not guaranteed for accuracy or completeness. No warranty, express or implied, is provided. Portions of this content may have been reviewed or refined using AI tools to enhance grammatical accuracy and sentence structure. Past performance is not indicative of future results. Investments are subject to market risks. Investors should consult a qualified financial advisor before making decisions. SEBI registration and NISM certification do not assure performance or returns. Any securities mentioned, if any, are purely illustrative and not recommendations.